As if egg-laying Australian mammals with webbed feet weren't fascinating enough, it turns out that their venom contains an insulin-stimulating peptide resistant to the forces that usually shorten its effectiveness in humans. Yes, they have venom.
Many previous studies have shown that smoking causes lung cancer, but a recently published report explained that heavy smokers with diabetes also have an increased risk of death unrelated to lung cancer.
It can be easy for providers to be lost in numbers as they go through a busy day in the clinic. However, there is evidence to suggest that finding different ways to help patients beyond symptom management can do as much if not more to help improve quality of life overall.
Patients with diabetes face a number of challenges in their daily life, especially monitoring their blood glucose levels. There is work being done in the medical community to monitor other potential issues that can affect quality of life overall and how to address them.
Novo Nordisk’s Xultophy combines a previously marketed basal insulin with a glucagon-like peptide-1 receptor agonist, and was yesterday accepted by the FDA. The company plans to have the drug on the market in 2017.